EP
Eversept Partners Portfolio holdings
AUM
$992M
1-Year Return
2.54%
This Quarter Return
+2.08%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$1.08B
AUM Growth
-$141M
(-12%)
Cap. Flow
-$141M
Cap. Flow
% of AUM
-13.03%
Top 10 Holdings %
Top 10 Hldgs %
53.14%
Holding
103
New
19
Increased
15
Reduced
30
Closed
24
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$32M |
| 2 |
Community Health Systems
CYH
|
$21.9M |
| 3 |
Organon & Co
OGN
|
$21.2M |
| 4 |
Ionis Pharmaceuticals
IONS
|
$17.6M |
| 5 |
RCM
R1 RCM Inc. Common Stock
RCM
|
$17.1M |
Top Sells
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$71.3M |
| 2 |
GSK
GSK
|
$30.3M |
| 3 |
TG Therapeutics
TGTX
|
$26.9M |
| 4 |
Elevance Health
ELV
|
$20.5M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
$17.2M |
Sector Composition
| 1 | Healthcare | 90.41% |
| 2 | Industrials | 1.59% |
| 3 | Financials | 0.07% |
| 4 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
ARK Innovation ETF
ARKK
$7.46B
| $11.1M | 0.74% |
85,000
+3,000
| +4% | +$392K |
|
27
Vertex Pharmaceuticals
VRTX
$102B
| $11M | 0.73% |
+54,500
| New | +$11M |
|
28
Cigna
CI
$81.2B
| $9.9M | 0.66% |
41,745
+1,745
| +4% | +$414K |
|
|
MGLN
29
DELISTED
Magellan Health Services, Inc.
MGLN
| $9.86M | 0.66% |
104,700
| – | – |
|
30
Alnylam Pharmaceuticals
ALNY
$59.4B
| $8.67M | 0.58% |
51,136
-29,801
| -37% | -$5.05M |
|
|
ZGNX
31
DELISTED
Zogenix, Inc.
ZGNX
| $8.57M | 0.57% |
495,860
-327,369
| -40% | -$5.66M |
|
32
Humana
HUM
$37.5B
| $8.27M | 0.55% |
18,656
-6,183
| -25% | -$2.74M |
|
33
Option Care Health
OPCH
$4.67B
| $6.33M | 0.42% |
+289,297
| New | +$6.33M |
|
34
Outset Medical
OM
$237M
| $5.36M | 0.36% |
+7,153
| New | +$5.36M |
|
35
Centene
CNC
$14.1B
| $4.96M | 0.33% |
68,000
-23,120
| -25% | -$1.69M |
|
|
SRGA
36
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $4.91M | 0.33% |
129,403
+41,410
| +47% | +$1.57M |
|
|
AFMD
37
DELISTED
Affimed
AFMD
| $4.82M | 0.32% |
56,694
-47,919
| -46% | -$4.07M |
|
|
ITCI
38
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $4.79M | 0.32% |
117,462
-183,125
| -61% | -$7.48M |
|
|
39
GSK
GSK
$79.8B
| $4.61M | 0.31% |
90,143
-591,622
| -87% | -$30.3M |
|
40
Cullinan Oncology
CGEM
$408M
| $4.22M | 0.28% |
+163,880
| New | +$4.22M |
|
41
DexCom
DXCM
$31.7B
| $4.07M | 0.27% |
38,100
-36,864
| -49% | -$3.94M |
|
|
42
Elevance Health
ELV
$69.4B
| $3.87M | 0.26% |
10,132
-53,760
| -84% | -$20.5M |
|
|
KDMN
43
DELISTED
Kadmon Holdings, Inc.
KDMN
| $3.46M | 0.23% |
894,995
-478,124
| -35% | -$1.85M |
|
44
Exelixis
EXEL
$10.1B
| $3.28M | 0.22% |
+180,000
| New | +$3.28M |
|
|
AUTL
45
Autolus Therapeutics
AUTL
$386M
| $3.14M | 0.21% |
+473,074
| New | +$3.14M |
|
46
Maravai LifeSciences
MRVI
$341M
| $3.13M | 0.21% |
+75,000
| New | +$3.13M |
|
|
XENT
47
DELISTED
Intersect ENT, Inc
XENT
| $3M | 0.2% |
175,389
+100,000
| +133% | +$1.71M |
|
48
Century Therapeutics
IPSC
$41.4M
| $2.96M | 0.2% |
+100,901
| New | +$2.96M |
|
49
Liquidia Corp
LQDA
$2.48B
| $2.8M | 0.19% |
979,049
+479,039
| +96% | +$1.37M |
|
|
50
TG Therapeutics
TGTX
$5.06B
| $2.71M | 0.18% |
69,760
-692,829
| -91% | -$26.9M |
|